Michael S Firstenberg
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 10, 2024
Exeporfinium chloride (XF-73) nasal gel significantly reduces <i>Staphylococcus aureus</i> nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study.Julie E Mangino, Michael S Firstenberg, William Rhys-Williams
|Mar 23, 2023
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced <i>Staphylococcus aureus</i> nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study.Julie E Mangino, Michael S Firstenberg, Rita K C Milewski
|Apr 26, 2021
Multi-institutional Analysis of 100 Consecutive Patients with COVID-19 and Severe Pulmonary Compromise Treated with Extracorporeal Membrane Oxygenation: Outcomes and Trends Over Time.Jeffrey P Jacobs, Alfred H Stammers, James St Louis
|May 13, 2020
Successful COVID-19 rescue therapy by extra-corporeal membrane oxygenation (ECMO) for respiratory failure: a case report.Michael S Firstenberg, Philip F Stahel, Jennifer Hanna
|Apr 23, 2020
Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients.Jeffrey P Jacobs, Alfred H Stammers, James St Louis
Pageof 1
